Log in | Register

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 16, Issue 1

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 16, Issue 1 (2017)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 16, Issue 1 (2017)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Volume 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?

Daniel Wendling, Frank Verhoeven, Xavier Guillot & Clément Prati

Pages: 1-3

Published online: 27 Oct 2016

First Page PreviewforImmunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers? | Full Text | References | PDF (252 KB)

2234 Views
6 CrossRef citations
0Altmetric

Free Access

Original Research

Article

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

Hélène Haguet, Jonathan Douxfils, François Mullier, Christian Chatelain, Carlos Graux & Jean-Michel Dogné

Pages: 5-12

Published online: 28 Nov 2016

AbstractforRisk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis | Full Text | References | PDF (1.3 MB) | Supplemental

990 Views
38 CrossRef citations
0Altmetric

Review

Cardiovascular safety of therapies for type 2 diabetes

Puneet Gupta & William B. White

Pages: 13-25

Published online: 11 Oct 2016

AbstractforCardiovascular safety of therapies for type 2 diabetes | Full Text | References | PDF (944.7 KB)

958 Views
7 CrossRef citations
0Altmetric

Review

Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release

Bruno Halpern & Marcio C. Mancini

Pages: 27-39

Published online: 24 Oct 2016

AbstractforSafety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release | Full Text | References | PDF (1 MB)

908 Views
28 CrossRef citations
0Altmetric

Review

The safety of anti PD-1 therapeutics for the treatment of melanoma

Egle Ramelyte, Sabrina A. Schindler & Reinhard Dummer

Pages: 41-53

Published online: 24 Oct 2016

AbstractforThe safety of anti PD-1 therapeutics for the treatment of melanoma | Full Text | References | PDF (1.2 MB)

657 Views
15 CrossRef citations
0Altmetric

Review

Statin intolerance – a question of definition

Engi Abdel-Hady Algharably, Iris Filler, Stephanie Rosenfeld, Katja Grabowski & Reinhold Kreutz

Pages: 55-63

Published online: 27 Sep 2016

AbstractforStatin intolerance – a question of definition | Full Text | References | PDF (702 KB)

697 Views
14 CrossRef citations
0Altmetric

Review

A review of the National pharmacovigilance system in Malta – implementing and operating a pharmacovigilance management system

Amy Tanti, Benjamin Micallef, Anthony Serracino-Inglott & John-Joseph Borg

Pages: 65-76

Published online: 24 Oct 2016

AbstractforA review of the National pharmacovigilance system in Malta – implementing and operating a pharmacovigilance management system | Full Text | References | PDF (1.1 MB)

184 Views
3 CrossRef citations
0Altmetric

Review

Hyponatremia induced by antiepileptic drugs in patients with epilepsy

Xi Lu & Xuefeng Wang

Pages: 77-87

Published online: 27 Oct 2016

AbstractforHyponatremia induced by antiepileptic drugs in patients with epilepsy | Full Text | References | PDF (822.9 KB)

2985 Views
43 CrossRef citations
0Altmetric

Review

Safety of monoclonal antibodies for the treatment of multiple sclerosis

Marisa P. McGinley, Brandon P. Moss & Jeffrey A. Cohen

Pages: 89-100

Published online: 31 Oct 2016

AbstractforSafety of monoclonal antibodies for the treatment of multiple sclerosis | Full Text | References | PDF (852.6 KB)

1743 Views
26 CrossRef citations
0Altmetric

Drug Safety Evaluation

Article

The safety of nivolumab for the treatment of advanced non-small cell lung cancer

Giulio Metro, Biagio Ricciuti, Marta Brambilla, Sara Baglivo, Irene Soli, Elisa Minenza, Giulia Costanza Leonardi, Alessandro D’arpino, Daniela Colabrese, Marco Tazza, Daniela Zicari, Vincenzo Minotti & Rita Chiari

Pages: 101-109

Published online: 11 Dec 2016

AbstractforThe safety of nivolumab for the treatment of advanced non-small cell lung cancer | Full Text | References | PDF (757.1 KB)

518 Views
7 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report

Wei Dou et al.

Article | Published online: 28 May 2024

Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the united states food and drug administration adverse event reporting system (FAERS)

Roger S. McIntyre et al.

Article | Published online: 28 May 2024

Risk of drug-induced delirium in older patients- a pharmacovigilance study of FDA adverse event reporting system database

Boying Jia et al.

Article | Published online: 26 May 2024

A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis

Rouhin Sen et al.

Review Article | Published online: 23 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.16, Iss.1, 2017)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?